tirzepatide prescribing information Weight loss injections (Mounjaro) We are working on a system to start Mounjaro (tirzepatide) for weight loss. The NHS guidelines state there is to be a phased introduction, starting with What clinicians should know about

Enjoy a FULL YEAR to try Fit ON and experience the results for yourself

& Lakoff, J

Heres what the clinical data shows: Most Common: Nausea (affecting 15-44% of users), diarrhea (10-30%), vomiting (7-25%), and constipation (6-24%) Severity: 98.1% of gastrointestinal side effects are mild or moderate, with 99.5% being non-serious Duration: Median duration is 8 days for nausea, 3 days for diarrhea, and 2 days for vomiting Timing: Most side effects occur during initial weeks and dose escalation, declining over time Discontinuation: Only 4.3-10% of users discontinue therapy due to side effects Serious Events: Rare, with no increased risk of pancreatitis or malignancy in clinical trials Management: Slow dose titration, dietary modifications, and hydration significantly reduce symptoms Important Note: Weight loss is NOT caused by side effects

But the scienceand the need to treat obesity as the chronic disease it isremains exactly the same